Jaap A Joles Selected Research

Overweight

1/2022	Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial.
11/2020	Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial.
10/2019	Assessment of real-time and quantitative changes in renal hemodynamics in healthy overweight males: Contrast-enhanced ultrasonography vs para-aminohippuric acid clearance.
3/2019	Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050.
1/2019	Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus.
1/2018	Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus Patients.
1/2018	Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials.
12/2017	Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.
11/2016	Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
1/2016	Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jaap A Joles Research Topics

Disease

37	Hypertension (High Blood Pressure) 01/2021 - 12/2001
28	Chronic Renal Insufficiency 05/2021 - 10/2007
21	Type 2 Diabetes Mellitus (MODY) 04/2023 - 01/2016
18	Proteinuria 01/2020 - 04/2000
17	Inflammation (Inflammations) 01/2020 - 02/2001
14	Fibrosis (Cirrhosis) 09/2020 - 06/2010
11	Chronic Kidney Failure (Chronic Renal Failure) 04/2021 - 04/2004
10	Overweight 01/2022 - 01/2016
8	Hypoxia (Hypoxemia) 01/2019 - 02/2013
7	Ischemia 01/2020 - 12/2001
6	Renal Insufficiency (Renal Failure) 05/2021 - 02/2001
6	Heart Failure 01/2021 - 11/2006
6	Albuminuria 01/2020 - 09/2007
6	Cardio-Renal Syndrome 01/2019 - 11/2006
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 06/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 03/2002
4	Acute Kidney Injury (Acute Renal Failure) 04/2021 - 02/2013
4	Kidney Diseases (Kidney Disease) 01/2020 - 04/2004
4	Anemia 01/2019 - 11/2006
4	Disease Progression 10/2017 - 08/2010
4	Hypercholesterolemia 12/2005 - 04/2000
3	Hypertriglyceridemia 04/2022 - 04/2000
3	Body Weight (Weight, Body) 01/2021 - 12/2017
3	Left Ventricular Dysfunction 09/2020 - 12/2010
3	Renal Hypertension 01/2020 - 12/2001
3	Pre-Eclampsia (Preeclampsia) 01/2020 - 11/2017
3	Myocardial Infarction 01/2016 - 02/2008
3	Glomerulonephritis 01/2012 - 08/2007
2	Uremia 01/2022 - 04/2021
2	Hyperglycemia 01/2022 - 01/2020
2	Insulin Resistance 01/2022 - 01/2020
2	Calciphylaxis 01/2021 - 03/2016
2	Birth Weight (Birth Weights) 08/2020 - 01/2019
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2020 - 11/2017

Drug/Important Bio-Agent (IBA)

18	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 12/2001
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2002
10	CreatinineIBA 04/2021 - 01/2012
9	Angiotensin IIIBA 01/2021 - 03/2004
9	SaltsIBA 01/2021 - 12/2011
8	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 10/2017
8	Nitric Oxide Synthase (NO Synthase)IBA 01/2020 - 12/2001
7	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 04/2005
7	Urea (Carbamide)FDA LinkGeneric 04/2021 - 02/2008
7	Connective Tissue Growth FactorIBA 01/2015 - 06/2006
6	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 01/2016
6	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021 - 03/2015
6	AlbuminsIBA 01/2018 - 03/2006
5	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 12/2017
5	Arginine (L-Arginine)FDA Link 01/2021 - 02/2001
5	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 05/2004
5	Biomarkers (Surrogate Marker)IBA 11/2020 - 09/2008
5	Molsidomine (SIN 10)IBA 12/2010 - 05/2002
4	SodiumIBA 12/2022 - 07/2003
4	dapagliflozinIBA 01/2022 - 01/2020
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
4	Gliclazide (Diamicron)IBA 01/2022 - 01/2020
4	Sodium-Glucose Transport ProteinsIBA 05/2021 - 01/2020
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 02/2004
4	Liraglutide FDA Link 01/2021 - 11/2016
4	Oxygen (Dioxygen)IBA 01/2020 - 01/2015
4	Erythropoietin FDA Link 01/2019 - 11/2006
4	lixisenatideIBA 01/2019 - 12/2017
4	insulin glulisine FDA Link 01/2019 - 12/2017
4	CholesterolIBA 09/2011 - 04/2000
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2010 - 02/2008
3	Insulin (Novolin)FDA Link 04/2023 - 11/2016
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 11/2016
3	AngiotensinsIBA 01/2021 - 07/2009
3	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 02/2004
3	ReninIBA 01/2021 - 07/2009
3	sodium thiosulfate FDA Link 01/2021 - 01/2020
3	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2020 - 11/2016
3	CitrullineIBA 08/2020 - 12/2007
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 07/2010
3	Exenatide (Byetta)FDA Link 10/2019 - 01/2016
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 11/2016
3	Insulin Glargine (Lantus)FDA Link 01/2019 - 12/2017
3	salicylhydroxamic acid (SHAM)IBA 01/2017 - 01/2011
3	EnzymesIBA 03/2016 - 03/2015
3	CollagenIBA 09/2012 - 02/2008
3	Messenger RNA (mRNA)IBA 09/2011 - 11/2008
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2022 - 11/2016
2	glimepiride (Amarel)FDA LinkGeneric 01/2022 - 11/2020
2	Uric Acid (Urate)IBA 01/2022 - 04/2020
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2022 - 04/2021
2	LinagliptinIBA 01/2022 - 11/2020
2	AntioxidantsIBA 01/2021 - 10/2017
2	AldosteroneIBA 01/2021 - 09/2007
2	Drinking WaterIBA 01/2021 - 01/2020
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2020 - 10/2017
2	Matrix Metalloproteinases (MMPs)IBA 09/2020 - 11/2008
2	Inulin FDA Link 01/2020 - 01/2020
2	p-Aminohippuric Acid (p-Aminohippurate)FDA Link 01/2020 - 10/2019

Therapy/Procedure

13	Therapeutics 05/2021 - 05/2004
5	Nephrectomy 01/2021 - 01/2012
5	Denervation 11/2020 - 07/2012
4	Transplantation 12/2021 - 08/2007
3	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2021 - 10/2007
3	Kidney Transplantation 01/2020 - 01/2015
2	Glycemic Control 12/2020 - 01/2020